These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Use of the HLA B27 test in Auckland. Thomas MG; Hart HH; Grigor RR; Gow PJ; Moore TE N Z Med J; 1984 Oct; 97(765):686-8. PubMed ID: 6333007 [TBL] [Abstract][Full Text] [Related]
24. Susceptibility and HLA-B27 in post-dysenteric arthropathies. van Bohemen CG; Lionarons RJ; van Bodegom P; Dinant HJ; Landheer JE; Nabbe AJ; Grumet FC; Zanen HC Immunology; 1985 Oct; 56(2):377-9. PubMed ID: 3902627 [TBL] [Abstract][Full Text] [Related]
25. [B27-positive diseases. A new concept in rheumatology (author's transl)]. Schattenkirchner M; Krüger K; Herzer P MMW Munch Med Wochenschr; 1980 Nov; 122(48):1725-8. PubMed ID: 6779137 [TBL] [Abstract][Full Text] [Related]
26. Whipple's disease in an HLA-B27 positive female. McKinley R; Grace CS Aust N Z J Med; 1985 Dec; 15(6):758-60. PubMed ID: 2423065 [TBL] [Abstract][Full Text] [Related]
31. [Human leukocyte B27 antigen in patients with seronegative arthritis]. Mladenović V; Kecman-Prunić B; Susaković N; Stolić I Srp Arh Celok Lek; 1983 Jun; 111(6):733-40. PubMed ID: 6607538 [No Abstract] [Full Text] [Related]
32. [Interdependence of ankylosing spondylitis and Crohn's disease]. Lysy Y; Branski D Harefuah; 1986 Jan; 110(1):26-7. PubMed ID: 3485554 [No Abstract] [Full Text] [Related]
33. Macroscopic and histological changes of the ileum HLA-B27 related diseases: therapeutic consequences. Mielants H; Veys EM; Cuvelier C; De Vos M Int J Clin Pharmacol Res; 1984; 4(6):409-14. PubMed ID: 6152438 [TBL] [Abstract][Full Text] [Related]
34. [Seronegative spondylo-arthropathies and HLA-B27]. Kaludi M Union Med Can; 1984 Jun; 113(6):455-9, 521. PubMed ID: 6333098 [No Abstract] [Full Text] [Related]
35. [Determination of HLA-B27 antigen. Indications and limitations]. Marcelli-Barge A; Poirier JC; Prévost P Presse Med; 1983 Apr; 12(15):931-3. PubMed ID: 6221245 [No Abstract] [Full Text] [Related]
36. Role of Chlamydia trachomatis and HLA-B27 in sexually acquired reactive arthritis. Keat AC; Maini RN; Nkwazi GC; Pegrum GD; Ridgway GL; Scott JT Br Med J; 1978 Mar; 1(6113):605-7. PubMed ID: 630254 [TBL] [Abstract][Full Text] [Related]
37. Non-utility of the HLA-B27 test. Merz D Ann Intern Med; 1982 Mar; 96(3):383-4. PubMed ID: 6977283 [No Abstract] [Full Text] [Related]
38. Complementation with HLA-A and HLA-D locus alleles in ankylosing spondylitis with peripheral arthritis. Aaron S; Miller ML; Howard J; Fraser PA; Jackson JM; Larson MG; Glass DN J Rheumatol; 1985 Jun; 12(3):553-7. PubMed ID: 3876437 [TBL] [Abstract][Full Text] [Related]
39. [Ankylosing spondylarthritis, HLA B27 and the theory of crossed tolerance]. Ebringer A Rev Rhum Mal Osteoartic; 1983 Nov; 50(11):763-9. PubMed ID: 6364315 [TBL] [Abstract][Full Text] [Related]
40. Ye-1, a monoclonal antibody that cross-reacts with HLA-B27 lymphoblastoid cell lines and an arthritis causing bacteria. Kono DH; Ogasawara M; Effros RB; Park MS; Waldord RL; Yu DT Clin Exp Immunol; 1985 Sep; 61(3):503-8. PubMed ID: 3878239 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]